Insider Trading Activity Healthways, Inc. – Director Sold 140,000 shares of Stock

ME Staff
-
0

Insider Trading Activity For Healthways, Inc.

Conan Laughlin , Director of Healthways, Inc. reportedly Sold 140,000 shares of the company’s stock at an average price of 34.9 for a total transaction amount of $4,886,000.00 SEC Form

Insider Trading History For Healthways, Inc.

  • On 5/9/2013 John W Ballantine, Director, sold 27,400 with an average share price of $14.02 per share and the total transaction amounting to $384,148.00.View SEC Filing
  • On 5/14/2013 Jay C Bisgard, Director, sold 18,343 with an average share price of $14.51 per share and the total transaction amounting to $266,156.93.View SEC Filing
  • On 5/17/2013 Jay C Bisgard, Director, sold 2,039 with an average share price of $14.50 per share and the total transaction amounting to $29,565.50.View SEC Filing
  • On 6/3/2013 Jay C Bisgard, Director, sold 4,869 with an average share price of $14.58 per share and the total transaction amounting to $70,990.02.View SEC Filing
  • On 8/14/2013 Ben Leedle, Jr., CEO, sold 293,984 with an average share price of $18.68 per share and the total transaction amounting to $5,491,621.12.View SEC Filing
  • On 8/14/2013 Alfred Lumsdaine, CFO, sold 9,425 with an average share price of $18.64 per share and the total transaction amounting to $175,682.00.View SEC Filing
  • On 10/29/2013 Alfred Lumsdaine, CFO, bought 5,000 with an average share price of $10.80 per share and the total transaction amounting to $54,000.00.View SEC Filing

    • Analyst Ratings For Healthways, Inc.
    These are 0 Sell Ratings, 1 Hold Rating, 5 Buy Ratings, 0 Strong Buy Ratings .
    The current consensus rating for Healthways, Inc. is Buy (Score: 2.83) with a consensus target price of $45.83 , a potential (30.58% upside)

    Analyst Ratings History For Healthways, Inc.

    • On 8/10/2016 FBR & Co Boost Price Target of rating Outperform with a price target of $16.00 to $21.00
    • On 8/10/2016 Piper Jaffray Companies Boost Price Target of rating Overweight with a price target of $15.00 to $25.50
    • On 8/22/2016 Barclays PLC Upgraded rating Underweight to Equal Weight with a price target of $12.00 to $27.00
    • On 9/25/2017 Jefferies Group LLC Reiterated Rating Buy with a price target of $46.00
    • On 10/27/2017 Chardan Capital Reiterated Rating Neutral to Neutral with a price target of $40.00 to $44.00
    • On 10/27/2017 SunTrust Banks, Inc. Set Price Target of rating Buy with a price target of $50.00
    • On 11/1/2017 Oppenheimer Holdings, Inc. Boost Price Target of rating Outperform with a price target of $47.00 to $50.00

    Recent Trading Activity for Healthways, Inc.
    Shares of Healthways, Inc. closed the previous trading session at with shares trading hands.